Gallstone recurrence after direct contact dissolution with methyl tert-butyl ether
- PMID: 7648979
- DOI: 10.1007/BF02212701
Gallstone recurrence after direct contact dissolution with methyl tert-butyl ether
Abstract
To determine the rate and characteristics of gallstone recurrence after direct contact dissolution with methyl tert-butyl ether, 60 consecutive patients were followed for up to 4.5 years (median 2.2 years) after complete disappearance of all stone residues and debris and cessation of adjuvant bile acid therapy. Initial gallstones had been multiple in all but four patients. Twenty-eight of the 60 patients developed recurrent gallstones. The cumulative risk of gallstone recurrence (actuarial analysis) was 23 +/- 6%, 34 +/- 7%, 55 +/- 8%, and 70 +/- 9% at one, two, three, and four years, respectively. The recurrent stones were usually multiple and small (6 +/- 4 mm). Gallstone recurrence was associated with recurrent biliary pain in two patients, one of whom developed acute cholecystitis. Recurrent stones were cleared completely by bile acid medication with or without shock-wave lithotripsy in 61 +/- 15% of patients at one year (actuarial analysis). In conclusion, gallstone recurrence after successful contact dissolution of multiple stones with methyl tert-butyl ether has to be expected in a high percentage of patients. Most patients, however, remain free of biliary pain during long-term follow-up.
Similar articles
-
Combination of extracorporeal shock-wave lithotripsy and dissolution of gallbladder stones with methyl tert-butyl ether: a randomized study.Hepatology. 1994 Jan;19(1):133-7. Hepatology. 1994. PMID: 8276350 Clinical Trial.
-
In vitro dissolution of cholesterol gallstones. A study of factors influencing rate and a comparison of solvents.Gastroenterology. 1985 Nov;89(5):1097-103. doi: 10.1016/0016-5085(85)90215-x. Gastroenterology. 1985. PMID: 4043667
-
Transhepatic topical dissolution of gallbladder stones with MTBE and EDTA. Results, side effects, and correlation with CT imaging.Dig Dis Sci. 1993 Nov;38(11):2121-9. doi: 10.1007/BF01297094. Dig Dis Sci. 1993. PMID: 8223089
-
Nonsurgical treatment of gallstone disease.Annu Rev Med. 1990;41:401-15. doi: 10.1146/annurev.me.41.020190.002153. Annu Rev Med. 1990. PMID: 2184740 Review.
-
Percutaneous contact dissolution of gallstones: complexity of radiologic care.Radiographics. 1991 Sep;11(5):759-70. doi: 10.1148/radiographics.11.5.1947312. Radiographics. 1991. PMID: 1947312 Review.
Cited by
-
Roles of infection, inflammation, and the immune system in cholesterol gallstone formation.Gastroenterology. 2009 Feb;136(2):425-40. doi: 10.1053/j.gastro.2008.12.031. Epub 2008 Dec 25. Gastroenterology. 2009. PMID: 19109959 Free PMC article. Review.
-
Outcome of gallbladder preservation in surgical management of primary bile duct stones.World J Gastroenterol. 2003 Aug;9(8):1871-3. doi: 10.3748/wjg.v9.i8.1871. World J Gastroenterol. 2003. PMID: 12918142 Free PMC article.
-
Gallbladder stone recurrence after medical treatment. Do gallstones recur true to type?Dig Dis Sci. 1995 Dec;40(12):2568-75. doi: 10.1007/BF02220443. Dig Dis Sci. 1995. PMID: 8536514
-
Therapy of gallstone disease: What it was, what it is, what it will be.World J Gastrointest Pharmacol Ther. 2012 Apr 6;3(2):7-20. doi: 10.4292/wjgpt.v3.i2.7. World J Gastrointest Pharmacol Ther. 2012. PMID: 22577615 Free PMC article.
-
Successful topical dissolution of cholesterol gallbladder stones using ethyl propionate.Dig Dis Sci. 1997 Jun;42(6):1274-82. doi: 10.1023/a:1018818527187. Dig Dis Sci. 1997. PMID: 9201095
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical